Zelira Therapeutics Ltd - ESG Rating & Company Profile powered by AI
Comprehensive ESG analysis of Zelira Therapeutics Ltd are accessed by registering for free. The analysis of Zelira Therapeutics Ltd leverages information from across the internet as well as from public filings by Zelira Therapeutics Ltd. This article contains a questions and answers table for Zelira Therapeutics Ltd.
Zelira Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 5.3, social score of 8.0 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
| 224 | Zelira Therapeutics Ltd | 7.1 | High |
| 224 | Celularity Inc | 7.1 | High |
| 224 | Bilcare Ltd | 7.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Zelira Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Zelira Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Zelira Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Zelira Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Zelira Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Zelira Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Zelira Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Zelira Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Zelira Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Zelira Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Zelira Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Zelira Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Zelira Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Zelira Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Zelira Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Zelira Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Zelira Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Zelira Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based medicines for the treatment of various medical conditions in Australia. The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid formulations to treat diabetes-associated cognitive decline. It offers formulations under the HOPE brand in Pennsylvania and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia. Zelira Therapeutics has strategic partnerships with Curtin University; the Telethon Kids Institute; the University of Western Australia; St. Vincent's Hospital; the Children's Hospital of Philadelphia (CHOP) on opioid reduction study; HAPA Pharm BV; and Ethicann. The company was formerly known as Zelda Therapeutics Limited and changed its name to Zelira Therapeutics Limited in December 2019. Zelira Therapeutics Limited was founded in 2003 and is headquartered in Perth, Australia.